Zhang Ze, Yang Tao, Zhao Mengya, Chen Huaqian
Department of Nephrology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, P. R. China.
Department of Cardiology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, P. R. China.
J Int Med Res. 2025 Jun;53(6):3000605251345954. doi: 10.1177/03000605251345954. Epub 2025 Jun 6.
BackgroundPrevious studies have shown that soluble growth-stimulated expression gene 2 protein (sST2) plays a significant role in the progression of maintenance hemodialysis. However, the relationship between sST2 and cardiovascular events in maintenance hemodialysis patients remains largely understudied.MethodThis study systematically searched PubMed, Wanfang, and other Chinese and English databases for all published studies on sST2 in maintenance hemodialysis. Relevant literature meeting the requirements was screened, and relevant data were extracted accordingly. The Newcastle-Ottawa Scale was used to evaluate the quality of the selected studies. Publication bias was assessed via funnel plots and Egger's test. A meta-analysis was performed using either a random-effects or fixed-effects model, as appropriate.ResultsA total of 10 high-quality studies were included in this study, with no significant publication bias. The meta-analysis revealed that sST2 level was associated with the incidence of cardiovascular events in maintenance hemodialysis patients (mean difference = 18.89, 95% confidence interval: 13.93-23.84; p<0.001). Moreover, elevated sST2 levels were correlated with a higher risk of cardiovascular events (odds ratio = 2.89, 95% confidence interval: 1.71-4.89; p<0.0001).ConclusionsST2 may serve as a predictive biomarker for cardiovascular events in maintenance hemodialysis patients.
以往研究表明,可溶性生长刺激表达基因2蛋白(sST2)在维持性血液透析进展中起重要作用。然而,sST2与维持性血液透析患者心血管事件之间的关系在很大程度上仍未得到充分研究。
本研究系统检索了PubMed、万方等中英文数据库中所有关于sST2在维持性血液透析中的已发表研究。筛选符合要求的相关文献,并相应提取相关数据。采用纽卡斯尔-渥太华量表评估所选研究的质量。通过漏斗图和Egger检验评估发表偏倚。根据情况使用随机效应或固定效应模型进行荟萃分析。
本研究共纳入10项高质量研究,无明显发表偏倚。荟萃分析显示,sST2水平与维持性血液透析患者心血管事件的发生率相关(平均差异=18.89,95%置信区间:13.93-23.84;p<0.001)。此外,sST2水平升高与心血管事件风险较高相关(优势比=2.89,95%置信区间:1.71-4.89;p<0.0001)。
ST2可能作为维持性血液透析患者心血管事件的预测生物标志物。